TheraQuest's IND for Abuse Deterrent Strong Opioid (TQ-1015) Accep... (evels when swallowed. It is also exceedi...)

TheraQuest's IND for Abuse Deterrent Strong Opioid (TQ-1015) Accepted by FDA

Date:11/12/2008

evels when swallowed. It is also exceedingly difficult for I.V. abusers to extract the active drug from the dosage form using common solvents, including alcohol.

About TheraQuest

TheraQuest Biosciences, Inc. (http://www.theraquestinc.com) is a private, development-stage pain management company building a diversified portfolio of pharmaceutical products to address a critical area of unmet medical need. Despite their limitations, current treatments for acute and chronic pain yield worldwide sales in excess of $30 billion. The TheraQuest team has contributed to the development of numerous analgesics approved in the U.S. over the past 20 years. TheraQuest's strategy is to use its expertise to identify, develop and commercialize product candidates with strong market potential that have lower development costs and reduced regulatory risk than new chemical entities. TheraQuest is headquartered in Blue Bell, Pennsylvania.

TheraQuest is funded in part by BioAdvance, the Biotechnology Greenhouse of Southeastern Pennsylvania and Ben Franklin Technology Partners of Southeastern Pennsylvania.

SECUREL(R) and OxyContin(R) are registered trademarks of TheraQuest Biosciences, Inc., and Purdue Pharma LP., respectively.

0

GOOD

Page: 1 2
Related medicine news :

1. Disability payments may spur drug abuse
2. Leading Child Abuse Center Releases Back to School Tips to Protect Children From Internet Predators
3. Inhalant Abuse Prevention Program to Be Launched in Maryland Schools
4. Research examines connection between substance abuse and violence
5. Steroids Are Abused for Skin, Not Just Muscles
6. L.A. Author, TV Personality and Substance Abuse Specialist Discusses Struggle to Break Bad-girl Syndrome Oct. 26-28 in Baltimore
7. Dealing with stress as a treatment for alcohol abuse
8. Culture can Affect Access to Alcohol, Drug Abuse Treatment for Rural Youth
9. King Pharmaceuticals and Acura Pharmaceuticals Enter Agreement to Develop and Commercialize Immediate Release Pain Medicines Utilizing Acuras Aversion(R) (Abuse-Deterrent) Technology
10. CHPA Commends Senator Biden on Legislation Aimed at Curbing Medicine-Abuse Trend
11. Substance abuse practitioners ask what is recovery?

Post Your Comments:

TheraQuest's IND for Abuse Deterrent Strong Opioid (TQ-1015) Accep...(evels when swallowed. It is also exceedi...),Health